Clinical Trial Update: Daptomycin in Treating Neutropenia and Fever in Patients With Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating daptomycin for treatment of neutropenia-associated fever and infection in cancer patients; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Infection
• Neutropenia
• Neutropenic Fever

Drugs mentioned

• Cubicin (daptomycin) (daptomycin)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Fever, Sweating | Phase 2 | Status: COMPLETED | Results posted: 2011-08-09